Corbus Pharmaceuticals Holdings (CRBP) Operating Expenses (2013 - 2025)
Corbus Pharmaceuticals Holdings (CRBP) posted quarterly Operating Expenses of $24.4 million for Q3 2025, up 57.48% year-over-year from $15.5 million in Q3 2024, and up 27.49% quarter-over-quarter from $19.2 million in Q2 2025.
Corbus Pharmaceuticals Holdings (CRBP) Operating Expenses (2013 - 2025) Analysis & Trends
Corbus Pharmaceuticals Holdings' Operating Expenses history runs 13 years deep, the most recent figure standing at $24.4 million for Q3 2025.
- In Q3 2025, Operating Expenses rose 57.48% year-over-year to $24.4 million; the TTM figure through Dec 2025 stood at $63.3 million (up 30.01% YoY), while the FY2024 annual figure was $48.7 million, up 8.08% from the prior year.
- Operating Expenses for Q3 2025 stood at $24.4 million, up from $19.2 million in the prior quarter.
- The five-year high for Operating Expenses was $24.4 million in Q3 2025, with the low at $8.2 million in Q3 2022.
- The 5-year median for Operating Expenses is $12.3 million (2022), against an average of $13.4 million.
- The sharpest annual moves came in 2021 and 2025: Operating Expenses tumbled 60.31% in 2021, then jumped 105.5% in 2025.
- Corbus Pharmaceuticals Holdings' Operating Expenses stood at $10.0 million in 2021, then gained by 7.99% to $10.8 million in 2022, then declined by 6.42% to $10.1 million in 2023, then increased by 24.75% to $12.6 million in 2024, then surged by 93.71% to $24.4 million in 2025.
- Business Quant data shows CRBP's Operating Expenses at $24.4 million in Q3 2025, $19.2 million in Q2 2025, and $19.8 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 2.09 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 3.00 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 2.89 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 960.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 1.21 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 1.06 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -784.57 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 427.03 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 541.02 Mn |
| 10 | Corbus Pharmaceuticals Holdings | 127.63 Mn | -35.64 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 24.42 Mn |
| Jun 30, 2025 | 19.15 Mn |
| Mar 31, 2025 | 19.78 Mn |
| Dec 31, 2024 | 12.61 Mn |
| Sep 30, 2024 | 15.51 Mn |
| Jun 30, 2024 | 10.99 Mn |
| Mar 31, 2024 | 9.62 Mn |
| Dec 31, 2023 | 10.10 Mn |
| Sep 30, 2023 | 9.49 Mn |
| Jun 30, 2023 | 8.19 Mn |
| Mar 31, 2023 | 17.30 Mn |
| Dec 31, 2022 | 10.80 Mn |
| Sep 30, 2022 | 8.18 Mn |
| Jun 30, 2022 | 12.34 Mn |
| Mar 31, 2022 | 8.52 Mn |
| Dec 31, 2021 | 10.00 Mn |
| Sep 30, 2021 | 13.97 Mn |
| Jun 30, 2021 | 16.84 Mn |
| Mar 31, 2021 | 16.06 Mn |
| Dec 31, 2020 | 21.47 Mn |